Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Presented by Sandra E. Kurtin,(1) PhDc, AOCN®, ANP-C, and Ann McNeill,(2) RN, MSN, APN
1)The University of Arizona Cancer Center, Tucson, Arizona; 2)John Theurer Cancer Center, Hackensack, New Jersey
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2018;9(3):351–356 |
© 2018 Harborside™
Identifying key molecular attributes can help in the risk-adapted treatment of Hodgkin lymphoma and chronic lymphocytic leukemia. At JADPRO Live, presenters reviewed best practices for managing patients with the rapidly expanding armamentarium of treatments for these patients.
For access to the full length article, please sign in